Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 5/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
| ▸ | DRD4 | P21917 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR7 | P34969 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3026097 | 0.70 | ELANE (0.44) | ELANERAB9ASMN1; SMN2SIGMAR1OPRM1 | |
| SCHEMBL7067422 | 0.69 | ELANE (0.42) | ELANERAB9ASMN1; SMN2SIGMAR1OPRM1 | |
| SCHEMBL12059191 | 0.68 | ELANE (0.41) | ELANERAB9ASMN1; SMN2SIGMAR1OPRM1 | |
| SCHEMBL4954884 | 0.68 | ELANE (0.41) | ELANERAB9ASMN1; SMN2SIGMAR1OPRM1 | |
| SCHEMBL9578136 | 0.64 | RAB9A (0.47) | ELANERAB9ASMN1; SMN2SIGMAR1OPRM1 | |
| SCHEMBL4858523 | 0.62 | RAB9A (0.47) | ELANERAB9ASMN1; SMN2SIGMAR1OPRM1 | |
| SCHEMBL25676835 | 0.62 | SMN1; SMN2 (0.75) | RAB9ASMN1; SMN2ALDH1A1NPC1GAA | |
| SCHEMBL22745995 | 0.62 | ELANE (0.62) | ELANESMN1; SMN2ALDH1A1SLC6A2KDM4E | |
| SCHEMBL10774814 | 0.61 | MAPT (0.45) | ELANESMN1; SMN2ALDH1A1MEN1KMT2A | |
| SCHEMBL23561017 | 0.60 | GRM5 (0.54) | RAB9ASMN1; SMN2SIGMAR1ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100181527-A1 | NITROXIDE CONTAINING ELECTRODE MATERIALS FOR SECONDARY BATTERIES | CIBA CORPORATION | 2010-07-22 | — | — | US | disclosed |
| WO-2008155247-A1 | NITROXIDE CONTAINING ELECTRODE MATERIALS FOR SECONDARY BATTERIES | BASF SE (CH) | 2008-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100181527-A1 | NITROXIDE CONTAINING ELECTRODE MATERIALS FOR SECONDARY BATTERIES | CAT, NQO1, NUCB2 | ELANE 841/4885RAB9A 1877/4885SMN1; SMN2 1860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.